Matches in SemOpenAlex for { <https://semopenalex.org/work/W3111505562> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W3111505562 endingPage "S701" @default.
- W3111505562 startingPage "S701" @default.
- W3111505562 abstract "The primary objective of this analysis was to compare the time to reimbursement (TTR) of orphan drugs (ODs) in five European countries: France, Germany, Italy, Spain and the United Kingdom (UK). A panel of 54 ODs with new active substances was created by selecting those approved by the EMA in the last 5 years. The dates of national reimbursement for these were also collected in each country from respective national authorities. TTR was defined as a difference between the date of the national approval/commercialization and the EC decision. The mean difference time to reimbursement varied considerably across countries, ranging in Germany from immediate reimbursement available after launch, “real time launch” 99 days (median 37) to 559 days (median 552) in Spain, passing through 281 days (median 227) in France, 463 days (median 350) in UK and 458 days (median 417) in Italy. Even within each single country ranges between min and max time to reimbursement were highly heterogeneous: 72-902 days for France; 67-1078 days for Italy; 132-1390 days for Spain; 135 - 1168 days for UK. Although drug's launch in Germany is possible immediately after the EC decision, ODs were commercialized within a timeframe of 7-826 days. The overall percentage of reimbursed drugs ranged from 51% in Spain to 95% in Germany; 68% in UK, 72% in Italy and 91% in France. Our analysis demonstrates a wide difference in TTR timelines, related to a great heterogeneity of assessment procedures applied across Europe. Current data also show that patients in Germany and France, compared to Italy, Spain and UK, have a faster access to ODs." @default.
- W3111505562 created "2020-12-21" @default.
- W3111505562 creator A5022705244 @default.
- W3111505562 creator A5023887020 @default.
- W3111505562 creator A5025374018 @default.
- W3111505562 creator A5043460705 @default.
- W3111505562 creator A5048680236 @default.
- W3111505562 creator A5075393370 @default.
- W3111505562 date "2020-12-01" @default.
- W3111505562 modified "2023-09-26" @default.
- W3111505562 title "PRO65 Time to Reimbursement for Orphan Drugs in EU5 in the Last FIVE YEARS" @default.
- W3111505562 doi "https://doi.org/10.1016/j.jval.2020.08.1801" @default.
- W3111505562 hasPublicationYear "2020" @default.
- W3111505562 type Work @default.
- W3111505562 sameAs 3111505562 @default.
- W3111505562 citedByCount "0" @default.
- W3111505562 crossrefType "journal-article" @default.
- W3111505562 hasAuthorship W3111505562A5022705244 @default.
- W3111505562 hasAuthorship W3111505562A5023887020 @default.
- W3111505562 hasAuthorship W3111505562A5025374018 @default.
- W3111505562 hasAuthorship W3111505562A5043460705 @default.
- W3111505562 hasAuthorship W3111505562A5048680236 @default.
- W3111505562 hasAuthorship W3111505562A5075393370 @default.
- W3111505562 hasBestOaLocation W31115055621 @default.
- W3111505562 hasConcept C144024400 @default.
- W3111505562 hasConcept C144133560 @default.
- W3111505562 hasConcept C149923435 @default.
- W3111505562 hasConcept C155202549 @default.
- W3111505562 hasConcept C160735492 @default.
- W3111505562 hasConcept C162324750 @default.
- W3111505562 hasConcept C187212893 @default.
- W3111505562 hasConcept C2779703844 @default.
- W3111505562 hasConcept C2910001868 @default.
- W3111505562 hasConcept C50522688 @default.
- W3111505562 hasConcept C512399662 @default.
- W3111505562 hasConcept C60644358 @default.
- W3111505562 hasConcept C71924100 @default.
- W3111505562 hasConcept C75480439 @default.
- W3111505562 hasConcept C86803240 @default.
- W3111505562 hasConceptScore W3111505562C144024400 @default.
- W3111505562 hasConceptScore W3111505562C144133560 @default.
- W3111505562 hasConceptScore W3111505562C149923435 @default.
- W3111505562 hasConceptScore W3111505562C155202549 @default.
- W3111505562 hasConceptScore W3111505562C160735492 @default.
- W3111505562 hasConceptScore W3111505562C162324750 @default.
- W3111505562 hasConceptScore W3111505562C187212893 @default.
- W3111505562 hasConceptScore W3111505562C2779703844 @default.
- W3111505562 hasConceptScore W3111505562C2910001868 @default.
- W3111505562 hasConceptScore W3111505562C50522688 @default.
- W3111505562 hasConceptScore W3111505562C512399662 @default.
- W3111505562 hasConceptScore W3111505562C60644358 @default.
- W3111505562 hasConceptScore W3111505562C71924100 @default.
- W3111505562 hasConceptScore W3111505562C75480439 @default.
- W3111505562 hasConceptScore W3111505562C86803240 @default.
- W3111505562 hasLocation W31115055621 @default.
- W3111505562 hasOpenAccess W3111505562 @default.
- W3111505562 hasPrimaryLocation W31115055621 @default.
- W3111505562 hasRelatedWork W139127264 @default.
- W3111505562 hasRelatedWork W1579507411 @default.
- W3111505562 hasRelatedWork W1791389912 @default.
- W3111505562 hasRelatedWork W2113338089 @default.
- W3111505562 hasRelatedWork W2395635671 @default.
- W3111505562 hasRelatedWork W2520491083 @default.
- W3111505562 hasRelatedWork W2900388326 @default.
- W3111505562 hasRelatedWork W3112440958 @default.
- W3111505562 hasRelatedWork W4200503229 @default.
- W3111505562 hasRelatedWork W4206917206 @default.
- W3111505562 hasVolume "23" @default.
- W3111505562 isParatext "false" @default.
- W3111505562 isRetracted "false" @default.
- W3111505562 magId "3111505562" @default.
- W3111505562 workType "article" @default.